Ideaya Biosciences Inc
IDYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.52B
Close$
$-1.63
104.5% downside
Current Fair Value
104.5% downsideOvervalued by 104.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.52 Billion |
|---|---|
| Enterprise Value | $3.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | -0.09 |
| Outstanding Shares | 92,061,452 |
Return
| Return on Equity | -14.60% |
|---|---|
| Return on Assets | -13.36% |
| Return on Invested Capital | -16.97% |
Valuation & Multiples
| P/E Ratio | -19.28 |
|---|---|
| PEG | -42.74 |
| Price to Sales | 18.34 |
| Price to Book Ratio | 2.82 |
| Enterprise Value to Revenue | 14 |
| Enterprise Value to EBIT | -15.73 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
$8.02 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
$9.92 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 78.51% |
|---|---|
| Total Calls | 80,100▼ 93.29% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.80%▼ 83.07% |
|---|---|
| Total Invested | $785.76M▼ 75.14% |
| Investors Holding | 99▼ 167.00% |
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata